Now that December is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in November – they’re ranked in order of popularity, with number one being the most viewed piece.
Posts Tagged ‘Precision Medicine’
Why And How Are Companies Investing In Precision Medicine
HIT Consultant, a digital publication focused on healthcare technology, recently shared a report by Reed Smith on mergers and acquisitions (M&A) in life sciences and how personalized medicine is playing an important role in many of today’s transactions. While pharmaceutical and biotechnology companies have not abandoned the “one-size-fits all” approach to developing drugs, many […]
Million Veteran Program: A Precision Medicine Project
In honor of Veterans Day, I thought it would be worth sharing a program that’s geared toward our beloved military veterans, yet helps society as a whole.
Targeting Prostate Cancer With Precision Medicine
Every time I hear about precision medicine showing signs of effective disease treatment, I want to share it with you. Here’s one to add to the collection.
Genentech: First In IT And Precision Medicine
Reading a recent LinkedIn Pulse post from Genentech’s VP of IT Americas, Cindy Elkins, made me smile. She said so many good things. Cindy discussed the IT landscape at the company, arguably the most famous biotech (ever!), and how the IT organization impacts employees and patients on many different levels.
First-Ever Rankings: Top 25 Companies In Precision Medicine
Thanks to one of my LinkedIn contacts, I was introduced to a newly released “scorecard” that ranks pharmaceutical and biotechnology companies based on their precision medicine efforts. In essence, the organizations who made the cut are the ones moving precision medicine forward. They’re the ones focused on leveraging biomarkers to develop new therapies.
Tackling Rare Diseases With Gene Therapy
A couple of weeks ago, I shared some statistics that I learned from an FDA blog post about rare diseases. While those numbers will make you cringe, Pfizer will give you hope. They, along with Spark Therapeutics, are teaming up to develop treatments for rare diseases, like hemophilia, through gene therapy. Gene therapy is […]
A Card That Fits In Your Genes
A few days ago, I read an article in The Atlantic about precision medicine. But it wasn’t about developing drugs for individuals with specific biomarkers. Instead, it discussed a simpler form of precision medicine that can prevent serious adverse events (SAEs). This method can actually fit in your wallet. It’s a card that houses […]
Transforming Care with Precision Medicine – 8 Emerging Trends
Molecular medicine is a broad field, where physical, chemical, biological and medical techniques are used to describe molecular structures and mechanisms, identify fundamental molecular and genetic errors of disease, and to develop molecular interventions to correct them. The molecular medicine perspective emphasizes cellular and molecular phenomena and interventions rather than the previous conceptual and observational […]
10 Tips On How To Discuss Genome Sequencing With Family Members
In 2009, the cost for a consumer to sequence his or her genome was $49,000. It’s all the way down to $1,000 today. As the price continues to become more affordable, the frequency of the average Joe sequencing his genome will likely increase. However, many individuals are wary of the idea of knowing more […]
Top 5 Life Sciences Blog Posts From September 2015
Now that October is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in September – they’re ranked in order of popularity, with number one being the most viewed piece.
Some Rare Disease Stats That Make Them Seem Rather Common
We often hear the term “rare disease,” yet many of us still wonder exactly how “rare” is defined. In a recent blog post, Dr. Jonathan Goldsmith, the FDA’s Associate Director for Rare Diseases, shared some staggering statistics, as well as insights into how the FDA is making it easier to develop drugs for unusual […]